Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 09, 2024 11:54 ET | Source: Research and Markets

Global Biobetters Market Analysis to 2034 by Drug Class, Disease Indication, Route of Administration, Distribution Channel, and Region, Featuring Exhaustive Profiles of the Top 10+ Players

Dublin, April 09, 2024 (GLOBE NEWSWIRE) -- The "Global Biobetters Market by Drug Class, by Disease Indication, by Route of Administration, by Distribution Channel, and By Region" report has been...
August 16, 2023 09:13 ET | Source: Research and Markets

Global Biosimilars Market Size, Share & Trends Analysis 2023 - 2030: Unlocking Affordable Therapies - The Increasing Role of Biosimilars in Patient Care

Dublin, Aug. 16, 2023 (GLOBE NEWSWIRE) -- The "Biosimilars Market Size, Share & Trends Analysis By Product (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins), By...
December 30, 2022 07:30 ET | Source: BiondVax Pharmaceuticals Ltd.

BiondVax CEO Issues Letter to Shareholders

JERUSALEM, Dec. 30, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biotechnology company focused on developing, manufacturing and commercializing...
June 15, 2021 06:18 ET | Source: Research and Markets

Insights on the Biosimilars Global Market to 2025 - Featuring Amgen, Cipla and Pfizer Among Others

Dublin, June 15, 2021 (GLOBE NEWSWIRE) -- The "Global Biosimilars Market 2020-2025" report has been added to ResearchAndMarkets.com's offering. The global biosimilars market should reach $60.1...